We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZOM
3451
DELISTED
Zomedica Corp.
ZOM
$14K ﹤0.01%
69,911
AIH
3452
DELISTED
Aesthetic Medical International Holdings
AIH
$13.9K ﹤0.01%
20,115
ANGI icon
3453
Angi Inc
ANGI
$196M
$13.6K ﹤0.01%
546
HNST icon
3454
The Honest Company
HNST
$586M
$13.3K ﹤0.01%
4,040
SRT
3455
DELISTED
Startek Inc.
SRT
$13.2K ﹤0.01%
3,000
VGAS icon
3456
Verde Clean Fuels
VGAS
$29.5M
$13.2K ﹤0.01%
5,606
+937
+20% +$2.88K
MTL
3457
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$13K ﹤0.01%
5,800
LCUT icon
3458
Lifetime Brands
LCUT
$211M
$13K ﹤0.01%
1,940
CVEO icon
3459
Civeo
CVEO
$318M
$13K ﹤0.01%
568
YI
3460
111 Inc
YI
$34.5M
$12.9K ﹤0.01%
833
MOB
3461
Mobilicom Ltd
MOB
$74.7M
$12.9K ﹤0.01%
+6,625
New +$10.3K
BNTX icon
3462
BioNTech
BNTX
$23.5B
$12.7K ﹤0.01%
120
ALTO icon
3463
Alto Ingredients
ALTO
$340M
$12.7K ﹤0.01%
4,756
HBB icon
3464
Hamilton Beach Brands
HBB
$422M
$12.2K ﹤0.01%
700
PAAS icon
3465
Pan American Silver
PAAS
$21.6B
$12.1K ﹤0.01%
743
CLLS
3466
Cellectis
CLLS
$285M
$11.9K ﹤0.01%
3,855
+885
+30% +$2.1K
CAE icon
3467
CAE Inc. Common Shares
CAE
$8.74B
$11.8K ﹤0.01%
546
GRPN icon
3468
Groupon
GRPN
$1.02B
$11.6K ﹤0.01%
903
SSYS icon
3469
Stratasys
SSYS
$774M
$11.5K ﹤0.01%
808
+520
+181% +$6.08K
IJJ icon
3470
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.97B
$11.4K ﹤0.01%
+100
New +$10.3K
STXS icon
3471
Stereotaxis
STXS
$141M
$11.3K ﹤0.01%
6,471
ESPR
3472
DELISTED
Esperion Therapeutics
ESPR
$11.3K ﹤0.01%
3,784
ABSI icon
3473
Absci
ABSI
$1.51B
$11.2K ﹤0.01%
2,676
EWU icon
3474
iShares MSCI United Kingdom ETF
EWU
$4.16B
$11.2K ﹤0.01%
340
FULC icon
3475
Fulcrum Therapeutics
FULC
$297M
$11.2K ﹤0.01%
1,657

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.